{ "Amino Acids for Pediatric Cardiac Surgery AKI", "This study is looking at whether giving amino acids (Trophamine) to children undergoing heart surgery is safe and practical. Some participants will receive a continuous infusion of Trophamine, while others will receive a placebo (lactated ringers solution). The main goal is to see how many participants experience side effects related to the amino acid infusion. This study is for children aged 1 day to 18 years who are having heart surgery and are at high risk for acute kidney injury (AKI). You cannot join if you have certain pre-existing kidney conditions or are already on life support. The study plans to enroll 30 participants, but its current recruitment status is unclear.", "design": "This is an interventional study comparing amino acids to a placebo in about 30 participants. It is not specified if participants or researchers will know which treatment is being given.", "commitments": "Participants will receive a continuous infusion of either amino acids or placebo starting at the time of cardiac surgery and continuing for up to 3 days. Adverse events will be monitored daily during the infusion and for up to 48 hours after it stops (up to 5 days total).", "compensation": "Not stated in the trial record.", "follow_up": "Participants will be monitored for adverse events for up to 5 days after the infusion begins.", }

Study design

Not specified.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.